Molecular data, vendor test results, and research background for the most commonly studied peptides.
A glucagon-like peptide-1 receptor agonist originally developed for type 2 diabetes management. Semaglutide has become one of the most widely discussed peptides due to its effects on metabolic regulation and body composition in clinical settings.
A dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. Tirzepatide represents a newer class of metabolic peptides targeting two incretin pathways simultaneously.